-transparent.png){kind=logo}
Two men are reported who developed cutaneous fibrosis indistinguishable from that encountered in progressive systemic sclerosis (PSS, scleroderma) after treatment with the antitumor agent, bleomycin. In vitro study of the dermal fibroblasts of 1 patient showed that these cells synthesized increased quantities of collagen and therefore resembled cells derived from individuals with naturally occurring PSS. Bleomycin was shown to stimulate collagen production by cultured normal skin fibroblasts. Also, in 1 of the patients, bleomycin stimulated a lymphoproliferative response in vitro. These effects of bleomycin may be responsible for certain toxic reactions to this drug in the skin and lung.
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
January 2004,
The Journal of the Association of Physicians of India,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
May 2012,
The Journal of dermatology,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
January 2011,
International journal of rheumatology,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
October 1996,
Journal of Korean medical science,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
February 2008,
Rheumatology (Oxford, England),
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
August 2018,
Turkish journal of medical sciences,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
February 2013,
Inflammation,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
February 2006,
Archives of dermatological research,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
September 2015,
European journal of rheumatology,
W R Finch, and
G P Rodnan, and
R B Buckingham, and
R K Prince, and
A Winkelstein
January 2013,
Veterinary pathology,
